About this journal

Aims and scope

Expert Review of Cardiovascular Therapy [ISSN 1477-9072]; [e-ISSN 1744-8344] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original papers in therapeutic cardiology.
Expert Review of Cardiovascular Therapy has provided an accessible and trusted forum for the evaluation of new diagnostic and therapeutic cardiovascular modalities for over a decade.

Articles focus on the following key areas:
Heart disease
Vascular disorders
Hypertension
Stroke
Heart failure
Cardiovascular surgery

Expert Review of Cardiovascular Therapy publishes a plethora of article types, such as clinically relevant Reviews, Editorials, Original Research and Drug Profiles. Correspondence through the submission of Letters to the Editor is also welcomed. Please note that the journal does not publish case reports or case series.
Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;
Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Authors can publish gold open access in this journal and may choose to publish using our Accelerated Publication services.

Read the For any pre-submission enquiries, please contact the Commissioning Editor.

Journal metrics

Usage

  • 147K annual downloads/views

Citation metrics

  • 1.8 (2023) Impact Factor
  • 2.1 (2023) 5 year IF
  • 3.7 (2023) CiteScore (Scopus)
  • Q2 CiteScore Best Quartile
  • 0.624 (2023) SNIP
  • 0.635 (2023) SJR

Speed/acceptance

  • 31 days avg. from submission to first decision
  • 75 days avg. from submission to first post-review decision
  • 7 days avg. from acceptance to online publication
  • 49% acceptance rate

Editorial board

Editor in Chief

Gregory YH Lip, University of Liverpool, UK 

Editor in Chief Emeritus

Dimitri Mikhailidis, University College London, London, UK

Editorial Board

Charalambos Antoniades, University of Oxford, UK

Marco Barbanti, University of Catania, Sicily, Italy

David A. Bluemke, NIH, MD, USA

Tze-Fan Caho, National Yang-Ming University, Taiwan

Yiannis Chatzizisis, Brigham and Women's Hospital, Harvard Medical School, MA, USA

Thomas Deneke, Heart Center Bad Neustadt, Germany

Robert S. Dieter, Loyola Univeristy, IL, USA

Marc Fisher, University of Massachusetts, MA, USA

Laurent Fauchier, University Hospital of Tours, France

Thomas G. Disalvo, Heart Failure Center, MA, USA

Larry B. Goldstein, Duke University Medical Center, NC, USA

Paolo Golino, University of Naples, Italy

Ian Jones, Liverpool John Moores University, UK

Ion Jovin, Virginia Commonwealth University, VA, USA

Masoor Kamalesh, Indiana University School of Medicine, USA

Kazu Kario, Jichi Medical School, Japan

Paul Khairy, University of Montreal, Canada

Gilbert L'italien, Bristol-Myers Squibb, CT, USA

Tong Liu, Tianjin Institute of Cardiology, Tianjin, China

Malek G. Massad, University of Illinois at Chicago, IL, USA

Farouk Mookadam, Cardiovascular Medicine Mayo Clinic, AZ, USA

Ryuichi Morishita R, Osaka University, Japan

Barbara J. Mulder, AMC, The Netherlands

Tasneem Naqvi, University of Southern California, CA, USA

Stephen J. Nicholls, Cleveland Clinic, USA

Sandra Ortega-Martorell, Liverpool John Moores University, UK

Davide Pacini, University of Bologna, Italy

Marco Proietti, University of Milan, Italy 

Rui Bebiano Da Providencia E Costa, University College London, UK

Umar Sadat, University of Cambridge, UK

Helmut Schühlen, German Heart Center, Germany

Jan A Staessen, University of Leuven, Belgium

Gregg W. Stone, The Cardiovascular Research Foundation, NY, USA

S. Adam Strickberger, Washington Hospital Center, USA

L-B Tan, Leeds General Infirmary, UK

Massimo Volpe, University of Rome 'Sapienza', Italy

Nanette Wenger, Emory University School of Medicine, GA, USA

Joseph Wu, Stanford University, CA, USA

Abstracting and indexing

Expert Review of Cardiovascular Therapy is included in the following abstracting and indexing services:

Emerging Sources Citation Index (ESCI); PubMed/MEDLINE/Index Medicus; EMBASE/Excerpta Medica; Emcare; Chemical Abstracts; Scopus; CINAHL® Plus.

Open access

Expert Review of Cardiovascular Therapy is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.

Use our APC finder to calculate your article publishing charge

News, offers and calls for papers

News and offers

Advertising information

Would you like to advertise in Expert Review of Cardiovascular Therapy?

Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Expert Review of Cardiovascular Therapy.

Explore advertising solutions

Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors